Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
investing
3
×
life sciences
national blog main
national top stories
new york blog main
3
×
new york top stories
biogen
biotech ipos
cancer immunotherapy
fda
medicare
national
san francisco blog main
san francisco top stories
startups
89bio
abbvie
acute myeloid leukemia
adrian krainer
alexion pharmaceuticals
alx oncology
alzheimer europe conference
alzheimer's disease
antisense oligonucleotide
astrazeneca
autoimmune diseases
bain capital
benzodiazepines
berkeley lights
blackstone group
blackstone life sciences
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
What
research
3
×
biotech
new
week
aims
alzheimer’s
annual
arrival
assessed
attention
backed
bio
cause
ceo
communities
companies
conference
days
drug
drugs
epilepsy
esmo
europe
genes
genetic
germany
hasn’t
hosted
industry
investment
ipo
ipos
life
links
marcio
market
medicines
momentum
munich
mutations
Language
unset
Current search:
investing
×
research
×
" new york blog main "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More